Case Report: Temozolomide Treatment of Refractory Prolactinoma Resistant to Dopamine Agonists

Therapeutic agents for refractory prolactinomas that are resistant to dopamine agonists (DAs) are troublesome, and surgery often only removes a large part of the tumor without complete remission. Among the various second-line treatment regimens, the treatment effect of the alkylating agent temozolom...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hao, Cheng, Yijun, Huang, Jinyan, Li, Jianfeng, Zhang, Benyan, Wu, Zhe Bao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996095/
https://www.ncbi.nlm.nih.gov/pubmed/33776913
http://dx.doi.org/10.3389/fendo.2021.616339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996095/
https://www.ncbi.nlm.nih.gov/pubmed/33776913
http://dx.doi.org/10.3389/fendo.2021.616339

Ejemplares similares